News
WXIBF
5.25
NaN%
--
Weekly Report: what happened at WXIBF last week (0323-0327)?
Weekly Report · 5d ago
CLSA Sticks to Their Buy Rating for Wuxi Biologics (Cayman) (WXIBF)
TipRanks · 03/28 01:37
Wuxi Biologics (Cayman) (WXIBF) Gets a Buy from UOB Kay Hian
TipRanks · 03/28 00:50
Daiwa Remains a Buy on Wuxi Biologics (Cayman) (WXIBF)
TipRanks · 03/28 00:49
Wuxi Biologics (Cayman) (WXIBF) Receives a Buy from CICC
TipRanks · 03/27 07:36
Wuxi Biologics (Cayman) (WXIBF) Gets a Buy from UBS
TipRanks · 03/27 05:48
Wuxi Biologics (Cayman) (WXIBF) Receives a Buy from Bank of China
TipRanks · 03/27 05:45
Wuxi Biologics (Cayman) (WXIBF) Receives a Hold from Bank of America Securities
TipRanks · 03/27 00:48
WuXi Biologics: Robust Backlog, High-Margin Growth Drivers, and Capacity Expansion Underpin Buy Rating
TipRanks · 03/26 06:05
Wuxi Biologics Grants 25.6 Million Restricted Shares Under Incentive Scheme
TipRanks · 03/25 13:10
Wuxi Biologics ADR Non-GAAP EPS of ¥1.33, revenue of ¥21.79M
Seeking Alpha · 03/24 12:18
WuXi Biologics Schedules Briefings on 2025 Annual Results for Global Investors
TipRanks · 03/24 11:39
Wuxi Biologics Delivers Strong 2025 Profit Growth as Project Portfolio Expands
TipRanks · 03/24 10:10
Weekly Report: what happened at WXIBF last week (0316-0320)?
Weekly Report · 03/23 09:16
Weekly Report: what happened at WXIBF last week (0309-0313)?
Weekly Report · 03/16 09:15
Weekly Report: what happened at WXIBF last week (0302-0306)?
Weekly Report · 03/09 09:16
Weekly Report: what happened at WXIBF last week (0223-0227)?
Weekly Report · 03/02 09:16
Weekly Report: what happened at WXIBF last week (0216-0220)?
Weekly Report · 02/23 09:16
Weekly Report: what happened at WXIBF last week (0209-0213)?
Weekly Report · 02/16 09:16
Zhongtai Securities Reaffirms Their Buy Rating on Wuxi Biologics (Cayman) (WXIBF)
TipRanks · 02/14 05:06
More
Webull provides a variety of real-time WXIBF stock news. You can receive the latest news about Wuxi Bio through multiple platforms. This information may help you make smarter investment decisions.
About WXIBF
WuXi Biologics (Cayman) Inc is an investment holding company principally engaged in the provision of end-to-end solutions and services for biologics discovery, development and manufacturing to customers involving in biologics industry. The Company mainly operates its business through two segments. The Biologics segment mainly engages in the provision of biologics discovery, development and manufacturing. The WuXi XDC (XDC) segment mainly engages in the provision of contract research, development and manufacturing organization (CRDMO) services for antibody-drug conjugate (ADCs) and various bioconjugates. The Company mainly conducts its business in the domestic and overseas markets.